Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210308979> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W3210308979 endingPage "415" @default.
- W3210308979 startingPage "408" @default.
- W3210308979 abstract "Introduction: Within the past 20 years, significant advances have taken place within the realm of aesthetic medicine to manage hair loss. Several human blood preparations have been found to contain regenerative properties suitable for hair rejuvenation and, subsequently, have emerged onto the market. An advanced and liquid version of platelet-rich fibrin, injectable platelet-rich fibrin (iPRF) is one such product. This article evaluates the combination of iPRF with microneedling (MN) for the treatment of male androgenetic alopecia (AGA) compared to other therapies. To knowledge, it is the first evaluation of its kind. Methods and materials: Secondary research was conducted via EMBASE, MEDLINE, PubMed and Cochrane Library databases to explore a preferred blood preparation and combination treatment using MN. Results and discussion: Secondary research shows that there is more in-depth evidence that suggests platelet-rich plasma (PRP) is the preferred blood preparation for treating male AGA at present. However, studies show that iPRF has greater regenerative potential. More research currently exists to suggest that MN in combination with minoxidil (MX) therapy is preferred over iPRF combined with MN alone. No validated patient-reported outcome measures (PROMs) currently exist for male AGA, although PROMs do exist for facial aesthetic treatments and alopecia areata. Conclusions: Studies show that iPRF combined with MN is a safe and effective option for the treatment of male AGA, but comparison studies against other combinations are lacking. Other monotherapy and combination methods are generally more evidenced. The secondary research also found that no specific PROM tool for measuring male AGA exists. Unless a specific PROM is developed and validated for male AGA, challenges around treatment comparison will continue to limit evidence." @default.
- W3210308979 created "2021-11-08" @default.
- W3210308979 creator A5029519919 @default.
- W3210308979 date "2021-11-02" @default.
- W3210308979 modified "2023-09-25" @default.
- W3210308979 title "Combination therapy with injectable platelet-rich fibrin and microneedling for male androgenetic alopecia: an evaluation of current practice" @default.
- W3210308979 cites W1563175580 @default.
- W3210308979 cites W2051909058 @default.
- W3210308979 cites W2105740912 @default.
- W3210308979 cites W2169542511 @default.
- W3210308979 cites W2292866786 @default.
- W3210308979 cites W2441187571 @default.
- W3210308979 cites W2529867849 @default.
- W3210308979 cites W2617145878 @default.
- W3210308979 cites W2719553259 @default.
- W3210308979 cites W2724281523 @default.
- W3210308979 cites W2742458606 @default.
- W3210308979 cites W2747848504 @default.
- W3210308979 cites W2762007216 @default.
- W3210308979 cites W2771059226 @default.
- W3210308979 cites W2810081498 @default.
- W3210308979 cites W2883993488 @default.
- W3210308979 cites W2913594613 @default.
- W3210308979 cites W2914480262 @default.
- W3210308979 cites W2947902590 @default.
- W3210308979 cites W2949561042 @default.
- W3210308979 cites W2949736964 @default.
- W3210308979 cites W3015702846 @default.
- W3210308979 cites W3031033669 @default.
- W3210308979 doi "https://doi.org/10.12968/joan.2021.10.9.408" @default.
- W3210308979 hasPublicationYear "2021" @default.
- W3210308979 type Work @default.
- W3210308979 sameAs 3210308979 @default.
- W3210308979 citedByCount "0" @default.
- W3210308979 crossrefType "journal-article" @default.
- W3210308979 hasAuthorship W3210308979A5029519919 @default.
- W3210308979 hasConcept C126322002 @default.
- W3210308979 hasConcept C141071460 @default.
- W3210308979 hasConcept C16005928 @default.
- W3210308979 hasConcept C168563851 @default.
- W3210308979 hasConcept C203014093 @default.
- W3210308979 hasConcept C2776360568 @default.
- W3210308979 hasConcept C2776478404 @default.
- W3210308979 hasConcept C2777524370 @default.
- W3210308979 hasConcept C2777560349 @default.
- W3210308979 hasConcept C2780076745 @default.
- W3210308979 hasConcept C54173615 @default.
- W3210308979 hasConcept C71924100 @default.
- W3210308979 hasConcept C89560881 @default.
- W3210308979 hasConceptScore W3210308979C126322002 @default.
- W3210308979 hasConceptScore W3210308979C141071460 @default.
- W3210308979 hasConceptScore W3210308979C16005928 @default.
- W3210308979 hasConceptScore W3210308979C168563851 @default.
- W3210308979 hasConceptScore W3210308979C203014093 @default.
- W3210308979 hasConceptScore W3210308979C2776360568 @default.
- W3210308979 hasConceptScore W3210308979C2776478404 @default.
- W3210308979 hasConceptScore W3210308979C2777524370 @default.
- W3210308979 hasConceptScore W3210308979C2777560349 @default.
- W3210308979 hasConceptScore W3210308979C2780076745 @default.
- W3210308979 hasConceptScore W3210308979C54173615 @default.
- W3210308979 hasConceptScore W3210308979C71924100 @default.
- W3210308979 hasConceptScore W3210308979C89560881 @default.
- W3210308979 hasIssue "9" @default.
- W3210308979 hasLocation W32103089791 @default.
- W3210308979 hasOpenAccess W3210308979 @default.
- W3210308979 hasPrimaryLocation W32103089791 @default.
- W3210308979 hasRelatedWork W1974651323 @default.
- W3210308979 hasRelatedWork W2168066640 @default.
- W3210308979 hasRelatedWork W2395293251 @default.
- W3210308979 hasRelatedWork W2405908831 @default.
- W3210308979 hasRelatedWork W2601895326 @default.
- W3210308979 hasRelatedWork W2724281523 @default.
- W3210308979 hasRelatedWork W2726589887 @default.
- W3210308979 hasRelatedWork W2949561042 @default.
- W3210308979 hasRelatedWork W3107277281 @default.
- W3210308979 hasRelatedWork W3210308979 @default.
- W3210308979 hasVolume "10" @default.
- W3210308979 isParatext "false" @default.
- W3210308979 isRetracted "false" @default.
- W3210308979 magId "3210308979" @default.
- W3210308979 workType "article" @default.